+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Advanced cervical carcinoma in Ibadan, Nigeria: an appraisal of radiation therapy

Advanced cervical carcinoma in Ibadan, Nigeria: an appraisal of radiation therapy

Journal of Obstetrics and Gynaecology 20(6): 624-627

This is a retrospective study of 500 patients with advanced cervical cancer (FIGO Stages IIB, III and IVA) who were seen and managed at the University College Hospital Ibadan between 1988 and 1992. External pelvic radiation therapy plus intractivary radioactive caesium brachytherapy was mainstay of treatment. Complete response to therapy was recorded in 68% of patients with stage IIB, 57% in stage III and 41.2% of patients in stage IVA. In patients with stage IIB, the local tumour control was 65%, in stage III patients 54% and in patients with stage IV 41%. The cumulative rates of survival at 5 years (for all the patients-with stage IIB, III and IVa) were 41.5%. The cumulative rates for disease-free survival at 5 years was 25.5%. Radiotherapy as the sole treatment modality in the management of advanced cervical cancer in Ibadan has yielded poor results as revealed in this study. There is an urgent need to evolve a new treatment policy with the aim of improving the response rate and survival in this group of patients.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 048190352

Download citation: RISBibTeXText

PMID: 15512681

DOI: 10.1080/01443610020001503

Related references

Histolopathological Patterns of Cervical Carcinoma Seen at A Radiotherapy Centre in Ibadan, Nigeria. Nigerian Quarterly Journal of Hospital Medicine 23(4): 334-337, 2016

Radiation therapy for advanced cervical carcinoma. Archives of Gynecology 235(1-4): 209-210, 1983

Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck. Journal of Cancer Research & Clinical Oncology 127(11): 687-691, 2001

Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501). Japanese Journal of Clinical Oncology 37(1): 70-72, 2007

Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. Cochrane Database of Systematic Reviews 2010(1): Cd006377, 2010

Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma LAUCC Kitasato Gynecologic Radiation Oncology Group KGROG 0501 - initial analysis. European Journal of Gynaecological Oncology 29(3): 222-224, 2008

Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 71(11): 3703-3706, 1993

Combination of radiation therapy and interferon alpha-2b in patients with advanced cervical carcinoma: a pilot study. International Journal of Gynecological Cancer 9(5): 401-405, 1999

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45(4): 616-623, 1995

Advanced cervical cancer therapy: concurrent radiation therapy and cisplatin chemotherapy for advanced cervical cancer--a toxicity report. American Journal of Clinical Oncology 12(6): 461-466, 1989

Economic appraisal of carcass condemnation in Ibadan, Nigeria. Global Journal of Pure and Applied Sciences 5(3): 293-298, 1999

Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity pharynx larynx and sinuses using radiation therapy as the only planned modality preliminary report by the radiation therapy oncology group rtog. International Journal of Radiation Oncology, Biology, Physics 13(1): 41-48, 1987

Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma. Cancer Radiotherapie 3(4): 345-347, 1999